The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 42

More JCP Articles

JCP
Sublingual Dexmedetomidine for Agitation in Schizophrenia
Original Research

October 3, 2022

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or schizoaffective disorder.
, , , et al
JCP
Reconsidering the Benefits of Pharmacological Interventions for Cognitive Adverse Effects of ECT
Clinical and Practical Psychopharmacology

October 3, 2022

Dr Andrade discusses the challenges of deciding whether and how to treat cognitive effects of electroconvulsive therapy.
JCP
Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder
Original Research

September 28, 2022

Prevalence and correlates of obsessive-compulsive symptoms and OCD were identified from the case records of over 22,500 patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
, , , et al
JCP
Asenapine, Aggression, and Affinity
Letter to the Editor

September 28, 2022

Dr El-Mallakh comments on a recent study by Citrome et al and discusses his group’s research on antiaggression effects of clozapine.
JCP
Antipsychotic Augmentation With N-Acetylcysteine in Schizophrenia
Clinical and Practical Psychopharmacology

September 26, 2022

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in schizophrenia.
JCP
Psychiatric Diagnoses in Transgender and Gender Diverse Patients
Original Research

September 26, 2022

This study drew on interviews of over 2,200 people to compare psychiatric diagnoses between transgender or gender diverse patients and cisgender patients presenting for psychiatric treatment.
, ,
JCP
LAI Antipsychotics in Schizophrenia: Long-term Outcomes of Early Use
Insights

September 21, 2022

Using data from the Taiwan National Health Insurance Research Database, Cheng-Yi Huang, MD, explains how he and Su-Chen Fang, PhD, and Yu-Hsuan Joni Shao, PhD, compared long-term effectiveness of…
JCP
C-Reactive Protein, Attention, and Gray Matter in Offspring of Patients With Bipolar Disorder
Original Research

September 21, 2022

Bipolar disorder is associated with inflammation and is a highly heritable illness. To identify potential biomarkers for BD, this study investigated correlations between inflammation, attention, and brain structure in…
, , , et al
JCP
Esketamine Nasal Spray and Adverse Events Over Time
Original Research

September 19, 2022

This study looked at the occurrence and severity of adverse events over time with esketamine nasal spray in MDD patients also receiving an oral antidepressant.
, , , et al
JCP
Engagement by Race/Ethnicity in Mental Health Interventions
Systematic Review

September 14, 2022

Observational studies show that individuals who are Black, Indigenous, and People of Color have less mental health care engagement than non-Latino Whites. This systematic review builds on those results…
, , , et al
JCP
Ketamine in the Real World: Where Do We Go From Here?
Commentary

September 14, 2022

Dr Wilkinson comments on recent data and developments in the use of ketamine for mood disorders.
JCP
Parental Mental Illness and Child Injury Risk
Original Research

September 12, 2022

Childhood injury is associated with parental serious mental illness (SMI). This study investigated whether the associations between parental SMI and child injury vary according to which parent had an…
, , , et al

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe